BioCentury
ARTICLE | Clinical News

Avanafil: Phase II data

May 2, 2005 7:00 AM UTC

In a double-blind, placebo-controlled, crossover Phase II study in 101 healthy males who received sublingual 0.4 mg glyceryl trinitrate (GTN), pretreatment with avanafil had less effect on HR and syst...